<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02460666</url>
  </required_header>
  <id_info>
    <org_study_id>R01AT008383-01A1</org_study_id>
    <nct_id>NCT02460666</nct_id>
  </id_info>
  <brief_title>Brain Connectivity and Response to Tai Chi in Geriatric Depression</brief_title>
  <official_title>Brain Connectivity and Response to Tai Chi in Geriatric Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects after up to 1 year of supervised weekly&#xD;
      Tai-Chi-Chi versus Health Education and Wellness classes on reduction of depressive symptoms&#xD;
      and improvement in resilience, health functioning, quality of life, cognition, sleep, fMRI&#xD;
      neural correlates of working memory, and brain structure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed randomized trial aims to investigate neural mechanisms of brain connectivity&#xD;
      when comparing response to TCC to health and wellness education classes using fMRI biomarkers&#xD;
      of emotional regulation and cognition. Control group will include health wellness education&#xD;
      programs (HEW) that will help to control for the non-specific social support factors. Primary&#xD;
      outcomes include measures of depressive symptom severity. Secondary outcomes include&#xD;
      cognition, resilience, health functioning, quality of life. Maintenance of response and&#xD;
      relapse of major depression will be determined during 6 month (and 12 month follow-up if MRI&#xD;
      eligible). Functional magnetic resonance imaging (fMRI) correlates of emotional processing&#xD;
      and connectivity in related functional networks. Neural correlates of working memory, and&#xD;
      brain structure will be examined in Â½ of the sample. The researchers will investigate whether&#xD;
      variations in emotional regulation will moderate or predict emotional and functional&#xD;
      improvement linked to TCC.&#xD;
&#xD;
      The investigators will recruit 220 older adults with depressive symptoms who have been on a&#xD;
      stable form of treatment for at least 4 months, who will be randomly assigned to 12 weeks of:&#xD;
      1.Ta-Chi-Chih (TCC) class; or 2. Health/Wellness Education Program (HEW); all for 120 minutes&#xD;
      per week. All subjects will receive comprehensive evaluations of mood, mental and physical&#xD;
      health, and cognition at baseline, 12 weeks, and 6 months. Changes over time in measures of&#xD;
      depressive symptoms, resilience, quality of life, and cognition will be assessed in random&#xD;
      regression models. The investigators anticipate that greater clinical improvement in mood and&#xD;
      cognition will in the TCC group compared to the HEW. The investigators also expect clinical&#xD;
      improvement to correlate with the change in the activation in the right ventrolateral&#xD;
      prefrontal cortex (VLPFC) and amygdala in an affect labeling task, and working memory-related&#xD;
      activation of dorsolateral prefrontal cortex (DLPFC), and change in functional connectivity&#xD;
      in brain network activity. This is the first randomized trial of response to TCC that&#xD;
      integrates the use of fMRI biomarkers of response to guide the development of treatment and&#xD;
      preventive approaches in geriatric depression.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">November 18, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hamilton Depression Rating Scale (HDRS) Scores</measure>
    <time_frame>Measured at baseline and 3 months</time_frame>
    <description>Clinician administered scale measures severity of depressive symptoms. This measure includes 24 items. Response options vary item to item and include the following ranges: [0-2], [0-3], and [0-4]. A score of 0 suggests absence of symptoms and/or difficulties and higher scores represent more severe difficulties. Possible overall score range [0-74], higher scores representing more severe difficulties.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Delayed Recall Cognitive Domain Scores</measure>
    <time_frame>Measured at baseline and 3 months</time_frame>
    <description>Neuropsychological battery of tests which included the following domains:&#xD;
Delayed Recall (CVLT-II [Long-Delay Free Recall], Rey-Osterrieth Complex Figure Test [30-minute Delayed Recall])&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Attention/Executive Function Cognitive Domain Scores</measure>
    <time_frame>Measured at baseline and 3 months</time_frame>
    <description>Neuropsychological battery of tests which included the following domains:&#xD;
Attention/Executive Function (Trail Making Test A and B, Stroop Interference [Golden version])&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Language Cognitive Domain Scores</measure>
    <time_frame>Measured at baseline and 3 months</time_frame>
    <description>Neuropsychological battery of tests which included the following domains:&#xD;
Language (Controlled Oral Word Association test [FAS], Animal Fluency, and Boston Naming Test)&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants With Adverse Events</measure>
    <time_frame>Measured at 3 months</time_frame>
    <description>The UKU (Udvalg for Kliniske Undersogelser) Side Effect Rating Scale organizes symptoms into 4 categories (i.e., Psychic, Neurologic, Autonomic, Other) containing 8-19 symptoms each. Each symptom receives a score for degree and causal relationship. Degree is scored between 0-3 with higher scores being more severe. Causal relationship is scored as improbable, possible, or probable.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Tai-Chi Chih Classes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health Education and Wellness Classes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tai-Chi-Chih (TCC)</intervention_name>
    <arm_group_label>Tai-Chi Chih Classes</arm_group_label>
    <other_name>Tai Chi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health Education and Wellness Classes (HEW)</intervention_name>
    <arm_group_label>Health Education and Wellness Classes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A 24-item Hamilton Rating Scale for Depression (HAMD) score greater than 14 consistent&#xD;
             with moderate-severe depression.&#xD;
&#xD;
          -  Mini-Mental State Exam (MMSE) score greater than 24.&#xD;
&#xD;
          -  Sufficient English proficiency and 8th grade or higher reading level as determined by&#xD;
             the word reading subtest of the Wide Range Achievement Test-IV.&#xD;
&#xD;
          -  Capacity to provide informed consent.&#xD;
&#xD;
          -  A stable form of treatment for at least 4 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any current or past psychiatric disorders, or recent unstable medical or neurological&#xD;
             disorders&#xD;
&#xD;
          -  Any disabilities preventing their participation in Tai-Chi Chih exercise (e.g. severe&#xD;
             visual or hearing impairment)&#xD;
&#xD;
          -  Insufficient English proficiency&#xD;
&#xD;
          -  Diagnosis of dementia&#xD;
&#xD;
          -  Mini Mental Health Examination score of 24 and below&#xD;
&#xD;
          -  Effective antidepressant, psychotropic medications, or effective therapy&#xD;
&#xD;
          -  Participation in a psychotherapy that involves cognitive training&#xD;
&#xD;
          -  Do not meet criteria for moderate-severe depression with a 24-item Hamilton Rating&#xD;
             Scale for Depression (HAMD) score less than 14&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helen Lavretsky, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA Semel Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Breen EC, Witarama T, Yokomizo M, Lavretsky H, Carroll JE, Motivala SJ, Bootzin R, Nicassio P. Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep. 2014 Sep 1;37(9):1543-52. doi: 10.5665/sleep.4008.</citation>
    <PMID>25142571</PMID>
  </reference>
  <reference>
    <citation>Siddarth D, Siddarth P, Lavretsky H. An observational study of the health benefits of yoga or tai chi compared with aerobic exercise in community-dwelling middle-aged and older adults. Am J Geriatr Psychiatry. 2014 Mar;22(3):272-3. doi: 10.1016/j.jagp.2013.01.065. Epub 2013 May 2.</citation>
    <PMID>23642461</PMID>
  </reference>
  <reference>
    <citation>Lavretsky H, Alstein LL, Olmstead RE, Ercoli LM, Riparetti-Brown M, Cyr NS, Irwin MR. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am J Geriatr Psychiatry. 2011 Oct;19(10):839-50. doi: 10.1097/JGP.0b013e31820ee9ef.</citation>
    <PMID>21358389</PMID>
  </reference>
  <reference>
    <citation>Schneider B, Ercoli L, Siddarth P, Lavretsky H. Vascular burden and cognitive functioning in depressed older adults. Am J Geriatr Psychiatry. 2012 Aug;20(8):673-81. doi: 10.1097/JGP.0b013e31822ccd64.</citation>
    <PMID>21857219</PMID>
  </reference>
  <reference>
    <citation>Abbott R, Lavretsky H. Tai Chi and Qigong for the treatment and prevention of mental disorders. Psychiatr Clin North Am. 2013 Mar;36(1):109-19. doi: 10.1016/j.psc.2013.01.011. Review.</citation>
    <PMID>23538081</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 16, 2015</study_first_submitted>
  <study_first_submitted_qc>May 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <results_first_submitted>May 25, 2021</results_first_submitted>
  <results_first_submitted_qc>June 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 9, 2021</results_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Helen Lavretsky, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>depressed</keyword>
  <keyword>older adults</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>Tai-Chi</keyword>
  <keyword>geriatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 2, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT02460666/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 13, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT02460666/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>220 participants were enrolled after providing consent and completing the screen visit. 178 participants completed baseline procedures and were randomized to either group.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Tai-Chi Chih Classes</title>
          <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
        </group>
        <group group_id="P2">
          <title>Health Education and Wellness Classes</title>
          <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="89"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tai-Chi Chih Classes</title>
          <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
        </group>
        <group group_id="B2">
          <title>Health Education and Wellness Classes</title>
          <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="89"/>
            <count group_id="B2" value="89"/>
            <count group_id="B3" value="178"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.2" spread="6.9"/>
                    <measurement group_id="B2" value="69.4" spread="6.2"/>
                    <measurement group_id="B3" value="69.3" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="129"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="168"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="153"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hamilton Depression Rating Scale</title>
          <description>Clinician administered scale measures severity of depressive symptoms. This measure includes 24 items. Response options vary item to item and include the following ranges: [0-2], [0-3], and [0-4]. A score of 0 suggests absence of symptoms and/or difficulties and higher scores represent more severe difficulties. Possible overall score range [0-74], higher scores representing more severe difficulties.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.0" spread="4.0"/>
                    <measurement group_id="B2" value="19.3" spread="3.9"/>
                    <measurement group_id="B3" value="19.15" spread="3.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Hamilton Depression Rating Scale (HDRS) Scores</title>
        <description>Clinician administered scale measures severity of depressive symptoms. This measure includes 24 items. Response options vary item to item and include the following ranges: [0-2], [0-3], and [0-4]. A score of 0 suggests absence of symptoms and/or difficulties and higher scores represent more severe difficulties. Possible overall score range [0-74], higher scores representing more severe difficulties.</description>
        <time_frame>Measured at baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tai-Chi Chih Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
          </group>
          <group group_id="O2">
            <title>Health Education and Wellness Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hamilton Depression Rating Scale (HDRS) Scores</title>
          <description>Clinician administered scale measures severity of depressive symptoms. This measure includes 24 items. Response options vary item to item and include the following ranges: [0-2], [0-3], and [0-4]. A score of 0 suggests absence of symptoms and/or difficulties and higher scores represent more severe difficulties. Possible overall score range [0-74], higher scores representing more severe difficulties.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.27" spread="5.29"/>
                    <measurement group_id="O2" value="-9.40" spread="5.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Delayed Recall Cognitive Domain Scores</title>
        <description>Neuropsychological battery of tests which included the following domains:&#xD;
Delayed Recall (CVLT-II [Long-Delay Free Recall], Rey-Osterrieth Complex Figure Test [30-minute Delayed Recall])&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
        <time_frame>Measured at baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tai-Chi Chih Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
          </group>
          <group group_id="O2">
            <title>Health Education and Wellness Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Delayed Recall Cognitive Domain Scores</title>
          <description>Neuropsychological battery of tests which included the following domains:&#xD;
Delayed Recall (CVLT-II [Long-Delay Free Recall], Rey-Osterrieth Complex Figure Test [30-minute Delayed Recall])&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
          <units>z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.57"/>
                    <measurement group_id="O2" value="-0.002" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Attention/Executive Function Cognitive Domain Scores</title>
        <description>Neuropsychological battery of tests which included the following domains:&#xD;
Attention/Executive Function (Trail Making Test A and B, Stroop Interference [Golden version])&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
        <time_frame>Measured at baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tai-Chi Chih Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
          </group>
          <group group_id="O2">
            <title>Health Education and Wellness Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Attention/Executive Function Cognitive Domain Scores</title>
          <description>Neuropsychological battery of tests which included the following domains:&#xD;
Attention/Executive Function (Trail Making Test A and B, Stroop Interference [Golden version])&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
          <units>z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.61"/>
                    <measurement group_id="O2" value="0.03" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Language Cognitive Domain Scores</title>
        <description>Neuropsychological battery of tests which included the following domains:&#xD;
Language (Controlled Oral Word Association test [FAS], Animal Fluency, and Boston Naming Test)&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
        <time_frame>Measured at baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tai-Chi Chih Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
          </group>
          <group group_id="O2">
            <title>Health Education and Wellness Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Language Cognitive Domain Scores</title>
          <description>Neuropsychological battery of tests which included the following domains:&#xD;
Language (Controlled Oral Word Association test [FAS], Animal Fluency, and Boston Naming Test)&#xD;
Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.</description>
          <units>z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.40"/>
                    <measurement group_id="O2" value="-0.12" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.09</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Adverse Events</title>
        <description>The UKU (Udvalg for Kliniske Undersogelser) Side Effect Rating Scale organizes symptoms into 4 categories (i.e., Psychic, Neurologic, Autonomic, Other) containing 8-19 symptoms each. Each symptom receives a score for degree and causal relationship. Degree is scored between 0-3 with higher scores being more severe. Causal relationship is scored as improbable, possible, or probable.</description>
        <time_frame>Measured at 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tai-Chi Chih Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
          </group>
          <group group_id="O2">
            <title>Health Education and Wellness Classes</title>
            <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Events</title>
          <description>The UKU (Udvalg for Kliniske Undersogelser) Side Effect Rating Scale organizes symptoms into 4 categories (i.e., Psychic, Neurologic, Autonomic, Other) containing 8-19 symptoms each. Each symptom receives a score for degree and causal relationship. Degree is scored between 0-3 with higher scores being more severe. Causal relationship is scored as improbable, possible, or probable.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89"/>
                <count group_id="O2" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected over the course of 6 months, from the time the participants began the intervention until the Week 24 follow-up.</time_frame>
      <desc>Adverse events were obtained via the UKU Side Effect Rating Scale, where items were scored on a 0-3 scale for degree (0 = none, 1 = mild, 2 = moderate, 3 = severe) and on a scale of 1-3 of probability if an adverse event was present (1 = impossibly related, 2 = possibly related, 3 = probably related).</desc>
      <group_list>
        <group group_id="E1">
          <title>Tai-Chi Chih Classes</title>
          <description>Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes.&#xD;
Tai-Chi-Chih (TCC)</description>
        </group>
        <group group_id="E2">
          <title>Health Education and Wellness Classes</title>
          <description>Participants will engage in 12 weekly 60 minute Health Education and Wellness classes.&#xD;
Health Education and Wellness Classes (HEW)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="89"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="89"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="89"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia/Lassitude/Increased Fatigability</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="89"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Failing memory</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="89"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Tension/Inner Unrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="89"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>After March 18th, 2020, all assessments were completed remotely due to COVID-19 until restrictions were lifted for eligible participants to come in-person.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Helen Lavretsky, MD</name_or_title>
      <organization>University of California, Los Angeles</organization>
      <phone>(310) 794-4619</phone>
      <email>HLavretsky@mednet.ucla.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

